Slide 1

Corporate PresentationMar 2014

Speed | Innovation | HappinessSpeed | Innovation | Happiness12OverviewSpeed | Innovation | Happiness

Overview3

Speed | Innovation | Happiness

Global footprint with world-class production facilities in America, Europe and AsiaSpeed | Innovation | Happiness5Corporate StructureSpeed | Innovation | Happiness

Business Verticles6Speed | Innovation | Happiness7Innovative Packaging Solutions

Our R&D PhilosophySpeed | Innovation | Happiness

PHARMA PACKAGING Innovations (PPI)8Speed | Innovation | HappinessFirst and only scientific packaging development study developed by Bilcare for the pharmaceutical solid dosage formulations

Studies and quantifies degradation pattern of the final formulation and suggests optimal packaging using software based mathematical modeling

Reliable tools to decrease time to market and offers the ability to select the optimal packaging from the beginning

Precursor to stability study

5Cs9Marketing initiativesto address the Pharma brand challenges PHARMA PACKAGING Core Offering

Bilcare OptimaSpeed | Innovation | HappinessPharma Packaging - Range of productsBilcare offers a complete range of high-quality packaging films. Our production standards are the highest in the business, with every film meeting complex and ever dynamic pharmaceutical specificationsSpeed | Innovation | HappinessGlobal Pharma Packaging CustomersGSKNovartisMerckSanofi AventisInternational Laboratories, Inc.Laboratorios Leti S.A.Reckitt Benckiser HealthcareLaboratrios Cinfa, S.A.ZakladyCILAG AstraZenecaBristol-Myers SquibbPfizerBluepharma BayerDelpharmCatalent Johnson & Johnson

Pharma Packaging Customers - Global11Speed | Innovation | HappinessPackaging Films Solutions (PFS)Leading suppliers of wide range of rigid Mono and Multilayer films for Food & FMCG industry

12Cards Solutions (CS)High quality cores and overlays for all kind of PVC Laminate Cards viz. Magnetic swipe cards, Gift & Loyalty cards, Banking Cards, Playing cards etc.

Specialty Films Solutions(SFS)

High quality Films for sectors such as Printing/ Decoration, Shrink lms, Visual packaging, Technical applications, Ofce materials and FurnitureSpeed | Innovation | Happiness13

Highly differentiated, next-gen anti-counterfeiting solution Large market opportunity

(approx 5% to 7% of the entire World trade is feared to be counterfeit *)Globally patented proprietary technology having applications beyond anti-counterfeitingNationally and internationally recognized

(Pioneer status from Govt. of Singapore)Razor sharp focus on operations

(Production capacity of over 1 Billion Chips )Strong partner/channel focus to drive scale quicklyHighly experienced, talented and focused leadership team* http://www.unc.edu/courses/2010spring/law/357c/001/ACG/stats.htmlnCID Technologies for Brand Safety & Security

13Speed | Innovation | Happiness

The nonClonableID Chip cannot be duplicated ever!Bilcares answer for Counterfeiting14Speed | Innovation | Happiness

Scanners and Mobile DeviceAuto ComponentsTextile labelClient portal

Wine & BeveragesPharma

Currency

Application across Industries

15

Central Server

Tamper evident nCID Chip

ID / Warranty / Loyalty cards

Speed | Innovation | HappinessnCID Technology - Business Impact16

Speed | Innovation | Happiness17

Global Clinical Supplies (GCS)Bilcare GCS delivers end-to-end solution that supports a Drug through the entire Clinical Trial life cycle

From pre-formulation to return & destruction accountability, our integrated offerings are aimed at establishing our customers critical success factor speed to market

Speed | Innovation | HappinessTRUST

TRUST

QUALITY FOUNDATION & INNOVATIONBilcare GCS Service Offerings 18Speed | Innovation | Happiness

19

Bilcare GCS FacilitiesGCS Facilities - IndiaPackaging & Labeling facilityStorage & DistributionBilcare GCS Global S&D NetworkIn Aug 2012, United Drugs Plc acquired Bilcares Global Clinical Supplies business in US and UK for USD 61 Mn. while Bilcare retained its GCS Asia business.

Going forward, Bilcare GCS, Asia and United Drugs Plc. will work together to use their complementary resources to meet the needs of their global customers across US, Europe and Asia.

Speed | Innovation | HappinessFinancial Overview20Share of International Business grown from 20% to 80% in the last 5 years Transformation to a Global CompanyNote: The above years denote Financial Year ending 31st March for that particular yearSpeed | Innovation | HappinessKey Financial Parameters P&L CONSOLIDATED (updated till 31st March 2014)21Note: The above years denote Financial Year ending 31st March for that particular yearSpeed | Innovation | HappinessProfit & Loss Account CONSOLIDATED22USD Mn.Particulars31-Mar-1131-Mar-1231-Mar-1331-Mar-14AuditedRevenue (incl. other income)455.20713.34 653.50 511.76Contribution200.15304.98271.44234.34% of Revenue44%43%42%46%Fixed Expenses126.47210.37199.34191.59EBITA73.6794.6172.1042.75% of Revenue16%13%11%8%Interest17.9332.1530.8036.15Depreciation16.7925.6227.3123.46PBT39.0836.8413.99(16.86)Tax9.739.463.463.82PAT29.2127.385.71(18.86)Speed | Innovation | Happiness23Note: The above years denote Financial Year ending 31st March for that particular yearKey Financial Parameters Balance Sheet CONSOLIDATED (updated till 31st March 2014)Speed | Innovation | HappinessBalance Sheet CONSOLIDATED 24USD Mn.Particulars31-Mar-1131-Mar-1231-Mar-1331-Mar-14AuditedEquity Capital4.604.604.333.92Networth (incl. deferred tax)244.00301.67277.01238.82Debt238.42267.90391.99364.53TOTAL487.02574.17673.33607.27Net Fixed Assets282.24320.01430.34397.47Investments0.040.020.020.02Net Current Assets204.74254.14242.98209.78TOTAL487.02574.17673.33607.27Speed | Innovation | Happiness25Note: The above years denote Financial Year ending 31st March for that particular yearKey Financial Parameters P&L STANDALONE INDIA (updated till 31st March 2014)Speed | Innovation | Happiness26Profit & Loss Account Standalone IndiaUSD Mn.Particulars31-Mar-1131-Mar-1231-Mar-1331-Mar-14AuditedRevenue (incl. other income)129.57148.33 133.7065.64Contribution52.0557.19 46.3820.34% of Revenue40%39%35%31%Fixed Expenses12.9512.45 12.8510.77EBIDTA39.1744.74 33.539.57% of Revenue30%30%25%25%Interest8.7715.58 18.8624.47Depreciation5.807.04 7.7311.28PBT24.6022.12 6.94(26.18)Tax7.587.51 0.910.22PAT17.0114.61 1.21(20.21)Speed | Innovation | Happiness27Note: The above years denote Financial Year ending 31st March for that particular yearKey Financial Parameters Balance Sheet INDIA STANDALONE (updated till 31st March 2014)Speed | Innovation | HappinessBalance Sheet Standalone India28USD Mn.Particulars31-Mar-1131-Mar-1231-Mar-1331-Mar-14AuditedEquity Capital4.604.604.333.92Reserves & Surplus (inccl. deferred tax)191.28204.03195.40155.37Debt106.08126.86251.48204.32TOTAL301.97335.49451.21363.61Net Fixed Assets99.90118.88261.61239.00Investments128.44132.79127.76113.67Net Current Assets73.6283.8261.8310.94TOTAL301.97335.49451.21363.61Speed | Innovation | Happiness

Bilcare Limited29Bilcare Limited, 601, ICC Trade Tower, Pune, India (Corporate office)www.bilcare.com Speed | Innovation | Happiness